To be given approval to sell a2 platinum formula in the US market until November 2022 would be a short term sugar hit, maybe we could jag $30 -$40 million NZD in sales.
The real upside is if A2 mngt and the FDA ( with help from NZ govt) can negotiate a longer term supply access deal and get the 17.5% Tariff waived so our products would be competitive with local infant formulas.
This would give A2 a real diversification from the Chinese market and provide serious scope to develop their US business including adding adult milk powders.
FDA Approval
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.15 |
Change
0.120(1.71%) |
Mkt cap ! $5.103B | |||
| Open | High | Low | Value | Volume |
| $6.99 | $7.15 | $6.95 | $10.19M | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 33024 | $7.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.15 | 68499 | 42 |
View Market Depth
| Last trade - 13.18pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.16 |
Change
0.120 ( 1.63 %) |
||||
| Open | High | Low | Volume | ||
| $6.98 | $7.16 | $6.95 | 478690 | ||
| Last updated 13.34pm 24/05/2024 ? | |||||
| A2M (ASX) Chart |